Lv21
118 积分 2024-09-25 加入
SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads
6天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
29天前
已完结
3D Scaffold-Based Culture System Enhances Preclinical Evaluation of Natural Killer Cell Therapy in A549 Lung Cancer Cells
1个月前
已完结
Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers
1个月前
已完结
Bispecific CAR T and CAR NK cells in dual-threat immunotherapy: opportunities and challenges
1个月前
已完结
Senti-202, a Selective, Off-the-Shelf, Preclinical CAR-NK Cell Therapy with CD33 and/or FLT3 Activating CAR, Healthy Cell Protection from Endomucin (EMCN) Inhibitory CAR and Calibrated Release IL-15 for Hematologic Malignancies Including AML
1个月前
已完结
靶向CD7的嵌合抗原受体NK-92MI细胞对CD7阳性血液系统恶性肿瘤细胞的杀伤作用
3个月前
已完结
Large-scale generation of iNK and CAR-iNK cells from CD34 haematopoietic stem and progenitor cells for adoptive immunotherapy+
3个月前
已完结
CAR-NK cells for haematological cancers
3个月前
已完结
皖公网安备34019202002308
